Register entry
Shenzhen Alvantis Pharma Co., Ltd.
- Registered sites
- 1
- Drug products
- 24
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Shenzhen Alvantis Pharma Co., Ltd. | ShenzhenChina | Active ingredient (API) manufacture | 3031629929 |
Catalogue
Marketed products
24Showing 24 of 24.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | AOD 9604 | POWDER | BULK INGREDIENT |
| - | Argireline | POWDER | BULK INGREDIENT |
| - | BPC-157 | POWDER | BULK INGREDIENT |
| - | BPC-157 Acetate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | BPC-157 Arginate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | BREMELANOTIDE ACETATE | POWDER | BULK INGREDIENT |
| - | CJC-1295 | POWDER | BULK INGREDIENT |
| - | Cagrilintide | POWDER | BULK INGREDIENT |
| - | Copper Peptide (GHK-Cu) | POWDER | BULK INGREDIENT |
| - | DSIP | POWDER | BULK INGREDIENT |
| - | Dihexa | POWDER | BULK INGREDIENT |
| - | Elamipretide | POWDER | BULK INGREDIENT |
| - | Epitalon | POWDER | BULK INGREDIENT |
| - | Ipamorelin | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Nicotinamide Adenine Dinucleotide | POWDER | BULK INGREDIENT |
| - | RETATRUTIDE | POWDER | BULK INGREDIENT |
| - | SERMORELIN ACETATE | POWDER | BULK INGREDIENT |
| - | Selank Acetate | POWDER | BULK INGREDIENT |
| - | Semaglutide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Semax | POWDER | BULK INGREDIENT |
| - | TB500 Fragment | POWDER | BULK INGREDIENT |
| - | TESAMORELIN | POWDER | BULK INGREDIENT |
| - | Thymosin Alpha-1 | POWDER | BULK INGREDIENT |
| - | Tirzepatide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.